<DOC>
	<DOCNO>NCT01068119</DOCNO>
	<brief_summary>Same day discharge safe feasible select troponin negative patient undergo coronary plan percutaneous coronary intervention ( PCI ) ad hoc PCI via transfemoral approach .</brief_summary>
	<brief_title>Same-Day Discharge After Coronary Percutaneous Transluminal Coronary Angioplasty ( PTCA )</brief_title>
	<detailed_description>The feasibility safety day discharge post PCI examine . Study data compare national registry national regional database PCI Troponin negative patient overnight stay . As part registry also assess compliance dual antiplatelet therapy six month 1 year record reason premature discontinuation well associated adverse event .</detailed_description>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<criteria>1 . Scheduled catheterization/coronary angiography 2 . Undergoing diagnostic coronary angiography define coronary anatomy intent revascularization ( adhoc PCI ) plan PCI define coronary anatomy intent revascularization due one following : 1. exertional rest chest pain ( angina equivalent ) 2. abnormal Exercise Stress Test 3. abnormal nuclear test 4. abnormal pharmacologic stress echocardiogram , pharmacologic MRI 5. abnormal EKGs 6. abnormal Calcium score 7. abnormal coronary CT angiogram 3 . Ability willingness consent Authorization use PHI 1 . ACS ( STEMI , UA/NSTEMI ) 2 . Positive Troponin I per local laboratory standard 3 . Known EF &lt; 30 % 4 . GFR &lt; 50 % ( calculation use IDMSTraceable MDRD study equation 5 . Dye Allergy unable safely premedicated 6 . Known current history bleed diathesis 7 . Current anticipate treatment warfarin , oral factor Xa inhibitor , oral direct thrombin inhibitor , LMWH , TNK 8 . Known platelet count &lt; 100,000/mmÂ³ know INR &gt; 1.5 time enrollment 9 . Hgb &lt; 10 g/dL and/or Hct &lt; 30 % 10 . Residence &gt; 60 minute hospital 11 . Reliable caregiver available home post PCI recovery 12 . Participation another study would require hospital procedure test post PCI prior discharge 13 . Inability unwillingness consent study , follow procedure Authorization use PHI 14 . Physician clinical determination participant suitable study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Acute coronary syndrome</keyword>
	<keyword>percutaneous coronary angioplasty</keyword>
	<keyword>Troponin negative</keyword>
	<keyword>cardiac</keyword>
</DOC>